SARS-CoV-2 collection

EVAg

SARS-CoV-2 collection

LATEST RESULTS: Visit our page dedicated to antiviral compounds test results against COVID19

Given the epidemiological situation concerning SARS-CoV-2, a simplified and faster procedure has been put in place for the supply of molecular diagnostics control and viral strains to the scientific community worldwide.

Here is the list of the available products on our website:
Virus Products
REF/SKU Variant
017V-04219 SARS-CoV-2 isolate - hCoV-19/France/BRE-IPP04392/2021, clade 20C, lineage B.1.616 20C/655Y (B.1.616)
017V-04212 Human SARS-CoV-2 - hCoV-19/French Guiana/IPP03772/2021, lineage P.1 20J/501Y.V3 (P.1)
017V-04211 SARS-CoV-2 isolate - BetaCoV/Mayotte/IPP00884/2021, lineage A.27
012V-04195 SARS-CoV-2, hCoV-19/Sweden/21-51217/2021 (lineage B.1.351, ex South African variant) 20H/501Y.V2 (B.1.351)
012V-04194 SARS-CoV-2, hCoV-19/Sweden/20-53840/2020 (lineage B 1. 1 .7, UK) 20I/501Y.V1 (B.1.1.7)
012V-04193 SARS-CoV-2, hCoV-19/Sweden/20-53787/2020 (lineage B 1. 1 .7, UK) 20I/501Y.V1 (B.1.1.7)
001V-04191 SARS-CoV-2 virus, strain SARS-CoV-2/2021/FR/4700 (lineage A27-like)
001V-04190 SARS-CoV-2 virus, strain SARS-CoV-2/2021/JP/TY7-503 (lineage P.1, ex Brazil) 20J/501Y.V3 (P.1)
001V-04189 SARS-CoV-2 virus, strain SARS-CoV-2/2021/JP/TY7-501 (lineage P.1, ex Brazil) 20J/501Y.V3 (P.1)
009V-04187 SARS-CoV-2, Human, 2021, Germany ex India, 20A/452R (B.1.617) 20A/452R (B.1.617)
008V-04186 SARS-CoV-2 variant G/484K.V3, isolate hCoV-19/Italy/LAZ-INMI-289/2021, clade G, Q52R, Δ69-70, Δ144, E484K, Q677H, F888L (S)
008V-04185 SARS-CoV-2 variant VOC 202012/01, isolate hCoV-19/Italy/LAZ-INMI-129isl/2020, clade GRY, Δ69-70, Δ144, N501Y, A570D, D614G, P681H, T716I (S) 20I/501Y.V1 (B.1.1.7)
006V-04183 SARS-CoV-2 strain Slovakia/SK-BMC-BA11/2021- B.1.351 variant (a.k.a. 20H/501Y.V2 or "South African variant") 20H/501Y.V2 (B.1.351)
005V-04144 SARS-CoV-2, strain hCoV-19/Slovenia/65006/21 (lineage A.27) (D796Y, G1219V, A653V, H655Y, N501Y) 19B/501Y (A.27)
005V-04110 SARS-CoV-2, strain hCoV-19/Slovenia/65882/21 (lineage A.27) (D796Y, G1219V, A653V, H655Y, N501Y) 19B/501Y (A.27)
005V-04109 SARS-CoV-2, strain hCoV-19/Slovenia/57573/21 (lineage B.1.525) 20A/484K (B.1.525)
005V-04107 SARS-CoV-2, strain hCoV-19/Slovenia/71693/21 (lineage B.1.351) 20H/501Y.V2 (B.1.351)
008V-04101 SARS-CoV-2 variant GR/501Y.V3, isolate hCoV-19/Italy/LAZ-INMI-216isl/2021, clade GR, PANGO lineage P.1, K417T, E484K, N501Y (S) 20J/501Y.V3 (P.1)
014V-04092 SARS-CoV-2 virus, strain hCoV-19/Netherlands/Gelderland_20949/2021, N501T (S), nextstrain clade 20D, lineage C.2
014V-04091 SARS-CoV-2 virus, strain hCoV-19/Aruba_11401/2021, California variant, nextstrain clade CAL.20C, lineage B.1.429 20C/452R (B.1.427/ B.1.429)
014V-04090 SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordBrabant_10706/2021, Brazilian variant P.2, nextstrain clade 20B, lineage B.1.1.28 P.2
014V-04089 SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordHolland_10915/2021, Brazilian variant P.1, nextstrain clade 20J, lineage B.1.1.28 P.1
017V-04087 Human 2019-nCoV - hCoV-19/France/PDL-IPP01065/2021, clade 20H/501Y.V2 20H/501Y.V2 (B.1.351)
006V-04083 SARS-CoV-2 strain Slovakia/SK-BMC-P1A/2021- B.1.1.7 variant (VOC 202012/01) 20I/501Y.V1 (B.1.1.7)
001V-04080 SARS-CoV-2 virus, isolate England/MIG457/2020 (lineage B.1.1.7) 20I/501Y.V1 (B.1.1.7)
004V-04071 Human nCoV19 isolate/England ex-SA/HCM002/2021 (lineage B.1.351) 20H/501Y.V2 (B.1.351)
001V-04067 SARS-CoV-2, UVE/SARS-CoV-2/2021/FR/1299-ex SA (lineage B 1.351) 20H/501Y.V2 (B.1.351)
014V-04058 SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordHolland_10159/2021, South African variant, nextstrain clade 20H, lineage B.1.351 20H/501Y.V2 (B.1.351)
017V-04055 Human 2019-nCoV - hCoV-19/France/IDF-IPP11324/2020, clade 20I/501Y.V1 20I/501Y.V1 (B.1.1.7)
005V-04053 SARS-CoV-2, strain hCoV-19/Slovenia/11454/21 (lineage B 1.1.7, exUK) 20I/501Y.V1 (B.1.1.7)
012V-04052 SARS-CoV-2, hCoV-19/Sweden/20-53846/2020 (lineage B 1. 1 .7, UK) 20I/501Y.V1 (B.1.1.7)
008V-04050 SARS-CoV-2 variant VOC 202012/01, isolate hCoV-19/Italy/CAM-INMI-118isl/2020, clade GR, Δ69-70, Δ144, N501Y, A570D, D614G, P681H, T716I (S)
008V-04049 SARS-CoV-2 isolate hCoV-19/Italy/LAZ-INMI-115isl/2020, clade G, D69-70, D614G (S)
008V-04048 SARS-CoV-2 isolate hCoV-19/Italy/LAZ-INMI-82isl/2020, clade GV, A222V, D614G (S)
008V-04047 SARS-CoV-2 isolate hCoV-19/Italy/LAZ-INMI-24/2020, clade GH, D614G (S)
001V-04044 SARS-CoV-2, UVE/SARS-CoV-2/2021/FR/7b (lineage B 1. 1 .7, ex UK) 20I/501Y.V1 (B.1.1.7)
004V-04032 Human nCoV19 isolate/England/MIG457/2020 (lineage B.1.1.7) 20I/501Y.V1 (B.1.1.7)
014V-04031 SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordHolland_20432/2020, VOC 202012/01, nextstrain clade 20I/501Y.V1, lineage B.1.1.7 20I/501Y.V1 (B.1.1.7)
014V-04030 SARS-CoV-2 virus, strain hCoV-19/Netherlands/NoordHolland_10006/2020, Netherlands ex Iran
001V-04006 SARS-CoV-2 virus, strain UVE/SARS-CoV2/2020/FR/ISA_D614
008V-04005 SARS-CoV-2 isolate SARS-CoV-2/Human/ITA/PAVIA10734/2020, clade G, D614G (S)
008V-03992 SARS-CoV-2 isolate SARS-CoV-2/human/ITA/INMI4/2020, clade GR, D614G (S)
002V-03991 SARS-CoV-2 human/DEU/HH-1/2020
014V-03981 SARS-CoV-2 virus, hCoV-19/Netherlands/NoordBrabant_10003/2020, clade B, D614 (S)
006V-03971 SARS-CoV-2 strain Slovakia/SK-BMC6/2020
014V-03968 SARS-CoV-2 virus, strain hCoV-19/Netherlands/ZuidHolland_10004/2020, clade B1.1, D614G (S)
001V-03967 SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2020/FR/702
005V-03961 SARS-CoV-2 strain Slovenia/SI-4265/20, D614G
017V-03960 Human 2019-nCoV - hCoV-19/France/GE1973/2020, clade G, D614G (S)
006V-03937 SARS-CoV-2 strain Slovakia/SK-BMC5/2020 FD
006V-03933 SARS-CoV-2 strain Slovakia/SK-BMC5/2020
010V-03903 SARS-CoV-2 strain /NL/2020
008V-03893 Human 2019-nCoV strain 2019-nCoV/Italy-INMI1, clade V
014V-03890 SARS-CoV-2 isolate - BetaCoV/France/IDF0372/2020
026V-03883 Human 2019-nCoV Isolate
Service Products
REF/SKU Variant
003S-03900 SARS-CoV-2 diagnostic training
026S-03464 Rapid reverse genetic as ISA on SARS-COV
006S-03089 Access to the UNIBAS BSL-3 infrastructure with theoretical and practical introduction and hands-on project training. Includes training in biosafety and safe work with RG3 viral pathogens
014S-03059 Institut Pasteur Paris - Management of biosafety and biosecurity in BSL3 containment facilities. The access will comprise a detailed theoretical and, subject to availability, practical application of the biosafety and biosecurity management of BSL3 in Ins
001S-02899 Training course: Next Generation Sequencing training for Ion torrent S5 sequencing
001S-02696 Training course: Lyophilization as a convenient method for long-term preservation of virus strains and derived products such as inactivated quality controls
003S-02038 Access to virus whole genome sequencing service at APHA
007S-01703 Access to UL infrastructure
009S-01682 Access to the INMI BSL-3 infrastructures for theoretical and practical training on biosafety and techniques related to RG3 virus isolation
002S-01572 Access to BSL-4 laboratory
001S-EVA363 Strain isolation from clinical sample
Protein Products
REF/SKU Variant
022P-04134 recombinant S1 protein (S1, aa 17-685) of SARS-CoV-2 SpyTag/StrepTag, glycosylated
022P-04124 recombinant N-terminal domain (NTD, aa 17-304) of SARS-CoV-2 SpyTag/StrepTag, glycosylated
022P-03958 recombinant receptor-binding domain (RBD)-SD1 (aa319-591) of SARS-CoV-2 TwinStrep-Tag
100P-03957 CTD of the SARS-CoV-2 nucleoprotein
100P-03956 NTD of the SARS-CoV-2 nucleoprotein
022P-03940 recombinant receptor-binding domain (RBD) of SARS-CoV-2 HisTag
Nucleic Acid Products
REF/SKU Variant
009N-04244 RNA SARS-CoV-2 strain B.1.617 (Germany ex India) 20A/452R (B.1.617)
001N-04192 RNA of UVE/SARS-CoV-2/2021/FR/1299-ex SA 20H/501Y.V2 (B.1.351)
014N-04150 SARS-CoV-2 RNA, strain hCoV-19/Netherlands/NoordHolland_10915/2021, Brazilian variant P.1, nextstrain clade 20J, lineage B.1.1.28 P.1
014N-04149 SARS-CoV-2 RNA, strain hCoV-19/Netherlands/NoordBrabant_10706/2021, Brazilian variant P.2, nextstrain clade 20B, lineage B.1.1.28 P.2
014N-04148 SARS-CoV-2 RNA, strain hCoV-19/Netherlands/Gelderland_20949/2021, N501T (S), nextstrain clade 20D, lineage C.2
014N-04147 SARS-CoV-2 RNA, strain hCoV-19/Netherlands/NoordHolland_10159/2021, South African variant, nextstrain clade 20H, lineage B.1.351 20H/501Y.V2 (B.1.351)
014N-04146 SARS-CoV-2 RNA, strain hCoV-19/Aruba_11401/2021, California variant, nextstrain clade CAL.20C, lineage B.1.429 20C/452R (B.1.427/ B.1.429)
005N-04125 SARS-CoV-2 RNA, strain hCoV-19/Slovenia/57573/21 (lineage B.1.525) 20A/484K (B.1.525)
005N-04108 SARS-CoV-2 RNA, strain hCoV-19/Slovenia/71693/21 (lineage B.1.351) 20H/501Y.V2 (B.1.351)
005N-04054 SARS-CoV-2 RNA, strain hCoV-19/Slovenia/11454/21 (lineage B 1.1.7, exUK) 20I/501Y.V1 (B.1.1.7)
001N-04051 RNA of SARS-CoV-2/2021/FR/7b (lineage B 1. 1 .7, ex UK) 20I/501Y.V1 (B.1.1.7)
006N-03939 SARS-CoV-2 strain Slovakia/SK-BMC5/2020, cDNA
006N-03938 SARS-CoV-2 strain Slovakia/SK-BMC5/2020, RNA
003N-03901 Wuhan coronavirus 2019 RdRP gene control
008N-03894 Human 2019-nCoV strain 2019-nCoV/Italy-INMI1 RNA
026N-03889 Human 2019-nCoV RNA
011N-03868 Coronavirus RNA specificity panel
026N-03866 Wuhan coronavirus 2019 E gene control
004N-02005 SARS-CoV Frankfurt 1 RNA
004N-EVA1407 MERS-CoV (hCoV-EMC) 1A assay (confirmatory assay)
004N-EVA1386 MERS-CoV (hCoV-EMC) upstream E (upE) assay (screening assay)
004N-EVA254 SARS-CoVFrankfurt 1 Isolate (IVT RNA)
Detection Kit Products
REF/SKU Variant
001K-03964 Lyophilized Primers and Probe for RT-PCR in the SARS-CoV-2 N (CUB) gene
001K-03954 SARS-CoV-2 N (CUB) gene stabilized RNA as positive control: shipping at Room Temperature
001K-03952 Lyophilized Primers and Probe for RT-PCR in the SARS-CoV-2 RdRp (IP4) gene
001K-03934 SARS-CoV-2 RdRp (IP2/IP4) gene stabilized RNA as positive control: shipping at Room Temperature
012K-03928 SARS-CoV-2 (2019-nCoV) IF-slides
001K-03906 Lyophilized Primers and Probe for RT-PCR in the SARS-CoV-2 RdRp gene
001K-03905 SARS-CoV-2 RdRp gene stabilized RNA as positive control: shipping at Room Temperature
001K-03885 Lyophilized Primers and Probe for RT-PCR in the 2019-nCoV E gene
001K-03884 2019-nCoV E gene stabilized RNA as positive control: shipping at Room Temperature
Bundle Products
REF/SKU Variant
001B-03965 Primers, Probe and encapsidated RNA pos. control - SARS-CoV-2 N (CUB) gene, small packaging
001B-03955 Primers, Probe and encapsidated RNA pos. control - SARS-CoV-2 RdRp (IP4) gene, small packaging
001B-03929 Primers, Probe and encapsidated RNA pos. control - SARS-CoV-2 RdRp gene, medium packaging
001B-03907 Primers, Probe and encapsidated RNA pos. control - SARS-CoV-2 RdRp gene, small packaging
001B-03888 Primers, Probe and encapsidated RNA pos. control - 2019-nCoV E gene, Large packaging
001B-03887 Primers, Probe and encapsidated RNA pos. control - 2019-nCoV E gene, Medium packaging
001B-03886 Primers, Probe and encapsidated RNA pos. control - 2019-nCoV E gene, small packaging
100B-03867 Diagnostics controls for Wuhan coronavirus 2019 / 2019-nCoV
Antibody or Hybridoma Products
REF/SKU Variant
024A-04029 SARS-CoV-2 nucleoprotein antiserum
024A-04028 SARS-CoV-2 nucleoprotein antiserum
015A-01748 murine mAb: anti-Severe acute respiratory syndrome coronavirus NP (anti-SARS NP)


HOW TO RECEIVE FREE OF CHARGE SARS-CoV-2 diagnostics controls and viral strains:
  1. Add only one SARS-CoV-2 related product at a time to your cart. Please note that for free of charge demands, only one product at a time should be ordered. If you want to request more than one product, simply place separate orders.

    If you have more than one product in your cart, you won't be able to select the "free of charge option". This procedure is necessary to allow proper evaluation of your demand by our Selection Panel, and for transparency reasons towards the European Commission who will be sponsoring financially your access.

  2. Create an account, or Log on to our portal
  3. Fill in the required billing and shipping information, intended use, and technical description. Please indicate if you need an import permit in case you ordered the SARS RNA control product.
  4. Don’t forget to tick the box for free of charge access
  5. Accept the terms and conditions* (mandatory)
  6. Complete you enquiry
Your enquiry will be forwarded to our Selection Panel that will evaluate your demand based on criteria defined in the European Commission specific provisions for transnational access activities guidelines.

This whole procedure will take less than 24h.

Once your enquiry is accepted, you will be put in contact with our EVA-GOBAL partner to arrange the shipment.

* May we bring your attention to clause 4 and 14 of EVA-GOBAL Terms and Conditions preventing redistribution of our products, and asking for citation of our organization in any publication resulting from the use of our products

LATEST RESULTS: Visit our page dedicated to antiviral compounds test results against COVID19

Comments (4)

  • Varsha Potdar's picture

    I applied online for the above mentioned positive control
    National Institute of virology pune is WHO designated national Influenza centre and worked for public helath important viruses .
    To have countries preparedness in place we required the positive control to set laboratory diagnosis

    Jan 18, 2020
  • Isabelle Thomas's picture

    We would like to order this control free of charge, fir the NIC Belgium in order to perform diagnosis of the new coronavirus

    Jan 20, 2020
  • K.Miyauchi's picture

    Thanks for these comments! Ordering these products is simple - we have described the process on this page under the title: HOW TO RECEIVE FREE OF CHARGE 2019-nCoV diagnostics controls.

    This comments section is not regularly monitored, so if you have any urgent questions about the products or the ordering process I would encourage you to contact us through our contact page that is available from the header and the footer menus of this page.

     

    Jan 23, 2020
  • RuoyuZhou's picture

    Hello,

    We request for diagnostic purposes.
    Our group is going to order the Coronavirus RNA specificity panel and the bundle of Wuhan coronavirus 2019 / 2019-nCoV Diagnositic control.
    But for the import permit, can you offer more info about the RNA including Source and the method of purification?

    Thank you very much.
    Regards,
    Ruoyu

    Feb 27, 2020
Connexion